On November 2, 2026, TuHURA Biosciences, Inc. borrowed an additional $1,500,000 from Parkview Holdings One LLC under a previously disclosed Loan Agreement. The borrowing is part of a revolving credit facility established on April 21, 2026, which provides for a maximum loan availability of $50 million and matures on April 21, 2031. The company intends to use the proceeds from this draw for general corporate purposes. TuHURA Biosciences operates in the biotechnology industry, focusing on the development of therapies.
